Ampio Pharmaceuticals, Inc. announced the start of construction of its new manufacturing facility for its drug candidate, Ampion(TM), for the treatment of patients afflicted with osteoarthritis of the knee. Located in the Denver Metro area, the facility is expected to be ready for production of Ampion(TM) in the summer of 2014 and should generate approximately 40 new jobs in the next two years.